We performed neuropsychological tests to investigate higher cortical dysfunction in 21 patients with systemic lupus erythematosus (SLE). We also measured antiphospholipid anti bodies (APA), performed brain computed tomography (CT), and obtained a single photon emission CT (SPECT) to measure regional cerebral blood flow (rCBF) in order to elucidate a possible relationship between APA and higher cortical dysfunction. Higher cortical dysfunction was noted in as many as 16 (76%) out of21 cases. APA were positive in 8 (38%) out of21 cases. Although the relationship between APA and higher cortical dysfunction was not significant, patients positive for lupus anticoagulant (LA) were found to have higher cortical dysfunction. Brain CT revealed at least one abnormality in 6 cases (29%) but none had a localized lesion, SPECT disclosed a reduced rCBF in 9 cases (43%). The findings on brain CT and SPECT were unrelated to higher cortical dysfunction.
Introduction
Among collagen diseases, SLE is known to be associated with a high incidence of CNS disorders and may, occasionally, be fatal. These CNS disorders may include hemjplegia, convulsion, thought derangement, involuntary movement, cranial nerve palsy and headache (1), and as suggested in a few reports, higher cortical dysfunction (1-4). To investigate higher cortical dysfunction in SLE in this study, we performed neuropsychological examinations on SLE patients. We also measured antiphospholipid antibodies, performed brain CT, and obtained a single photon emission CT (SPECT) to assess regional cerebral blood flow (rCBF) in an attempt to elucidate a possible relationship between antiphospholipid antibodies (APA) and higher cortical dysfunction.
Subjects and Methods
The subjects included 21 patients with SLE who fulfilled the 1982 revised criteria for the classification of SLE (5) and who were under medical treatment, consisting of 21 females, with a mean age of 33.0 ± 10.9 years (ranging from 13 to 50 years). Every patient was right-handed. As controls, 16 healthy subjects ranging in age from20to53 (mean age: 29.2 ± 9.1; all females) were studied and compared with the SLE group. All under went the following neuropsychological examinations: 1) Intelligence and mental function Mini-Mental State (MMS): This test was examined in accordance with the method of Folstein et al (6). "Kana"-pick up test: The examinees were instructed to pick out kana letters, "A, I, U, E and O" (Japanese vowels) and circle in sentences written laterally in kana which they could understand. If more than 20 such letters were selected within the time limit of two minutes, the result was considered normal. Miyake's paired associated memory scale: This test was performed in accordance with the method of Miyake introducted by Hasegawa (7). Word recall: The examinees were instructed to pro vide as many names of animals as possible during one From the Third Department of Internal Medicine, Wakayama Medical College, Wakayama Received for publication September 2, 1991; Accepted for publication July 28, 1992 Reprint requests should be addressed to Dr. Etsuko Maeshima, the Third Department of Internal Medicine, Wakayama Medical College, 7-Wakayama 640, Japan
Internal Medicine Vol. 31, No. 10 (October 1992) 1169 minute. If more than 12 names were listed, the result was considered normal. Digit span (forward): After the examiner named figures with three to nine digits (723, 4258, , 146897530 ) the examinee was asked to recite the numbers. Correct recitation of more than 5 digits was considered normal.
2) Linguistic function Aural comprehension, subjective speech, recitation, reading aloud, reading and understanding, writing, and dictation were examined in accordance with the method of Watamori (8).
3) Recognition and praxis Line-bisection test: The subjects were asked to bisect a 20 cm line. Deviation of more than 1 cm was considered abnormal. Line-cancellation task: Forty lines were drawn on a blank sheet of paper 29.6 X 21 cm in size, and the subject was asked to cancel out all of these lines. If more than 3 lines were left uncancelled the result was considered abnormal. Recognition of intricate pictures: The subjects were asked to name objects by tracing their pictures with their fingers. If more than 3 out of 5 objects went unnoticed, the test was considered abnormal. Perspective cube copying test: The subject was asked to copy the perspective drawing of a cube depicted on the upper half of a blank sheetof paper sized 29.6 x 21cm. The drawing was made by the more skillful hand. The criteria used to assess the result were those of Kato et al (9). The following blood and neuroradiological examin ations were also performed in studying the SLE patients. 1) Antiphospholipid antibodies (APA) Lupus anticoagulant (LA): The diluted prothrombin time (PT) was used to screen for LA in accordance with the method of Sirridge and Shannon (10). The ratios of coagulation time (diluted PT/ordinary PT) obtained were used to make the assessment. A ratio of less than 3.0 was considered negative, and that of 3.0 or more, positive. Anticardiolipin antibodies (ACA): A microplate ELISA method was used to detect ACA in accordance with the method of Hayama et al (ll). Any value ex ceeding the cut-off index of 1.0 was considered positive.
2) Neuroradiological examinations Brain CT: Slices were cut at 10mm from the OM line using a Toshiba TCT60-A. Low and high absorption fields were assessed. Atrophy of the cerebral cortex and expansion of cerebral ventricles were also noted. SPECT: Regional cerebral blood flow (rCBF) was measured by single photon emission computed tomo graphy (SPECT) using a Starcam 3000XC/T. 123I-IMP (N-isopropyl-p-iodoamphetamine) was used as a tracer of cerebral blood flow. Data was collected beginning 15 minutes after an i.v. injection of lll MBq of the tracer. Assessment of any reduction in rCBF was made by a neuroradiologist who was unaware of the patient's condition. The results of these examinations were com pared using Fisher's exact test or the grouped t-test. 
Neuroradiological examinations
Brain CT revealed cortical atrophy in 6 cases and cavum septi pellucidi in 1 case (Table 3) . No patient had a focal lesion. SPECT revealed reduced rCBF in 9 cases (43%). In 3 of these patients, reduced rCBF was noted in the right hemisphere and in the other 6 patients, rCBF reduction to both right and left was noted (Fig. 3) . Of the patients with higher cortical dysfunction, 8 had no abnormal finding on brain CT and SPECT, 1 had abnormalities only on brain CT, 4 had abnormalities only on SPECT, and 4 had abnormalities on both brain CT and SPECT. Thus, abnormal radiological test results were obtained in 8 out of 16 patients who had higher cortical dysfunction. The findings on brain CT and SPECT were not found to be related to higher cortical dysfunction. Discussion SLE is known, among collagen diseases, as a disease likely complicated by a CNS disorder. However, studies of higher cortical dysfunction in SLE patients are few (1 -4). Moreover, these studies used a fragmented neuro psychological approach, and no systematic approach has been completed. In the present study, we performed neuropsychological tests of intelligence, mental function, linguistic function and recognition and praxis to investi gate higher cortical dysfunction in SLE patients. On intelligence and mental function tests, including the MMS, "Kana"-pick up test, Miyake's paired assodated memory scale, word recall and digit span, an abnormality was noted in 52.4% (ll/21) of the patients studied. On the constructional praxis test using cube copying, 61.9% (13/21) of the patients demonstrated constructional apraxia. The incidence of such abnor malities on the described neuropsychological tests was significantly higher in the SLE group than in the healthy control group. Treatment with oral PSL was unrelated to higher cortical dysfunction. Furthermore, there were only three patients who were taking orally drugs such as sleep inducers and nonsteroidal antiinflammatory drugs.
One of these three patients was found to have no higher cortical dysfunction and another one was found to have been given antiinflammatory drugs only occasionaly, thus making it inconceivable that the drugs would have influenced the test results. Thus, the higher cortical dysfunction detected in the present study was considered to be associated with SLE itself. Carbotte et al (3) and Nagaoka et al (4) studied intel ligence and mental function in SLE patients, using the Wechsler adult intelligence scale (WAIS), Wechsler memory scale, and Miyake's paired associated memory scale. In the present study, the incidence of abnormalities was the highest on the Miyake's paired associated memory scale test, suggesting that effects on the limbic system, the hypothesized center of memory, are common in SLE. The present report is the first to document con structional apraxia in patients with SLE. Constructional apraxia, which is reported to occur in the presence of both focal and diffuse lesions in the cerebrum, seems to AXIAL AXIAL SAGITTAL CORONAL Patient 7 CORONAL Patient 8 Fig. 3 . SPECT studies of two patients. In case 7, reduced rCBF was noted bilaterally in the frontal lobes. In case 8, reduced rCBF was noted in the right temporoparietal lobes.
be a useful indicator of cerebral dysfunction. On the other hand, there was no relationship between higher cortical dysfunction and the patients' subjective symptoms, and cerebral disorders were present even in patients who had no complaints. Thus, neuropsycholog ical tests seem to be useful for detecting such disorders. In most of the present patients, SLE was inactive and a higher incidence of higher cortical dysfunction was noted in these patients. Therefore, higher cortical dysfunction is believed to be exist in SLE irrespective of the activity of SLE. During follow-up observations, however, the ability of one patient (# 8) to copy a cube varied with the SLE activity/ In one patient (# 10), memory and constructional apraxia were improved after remission of the SLE activity was induced by treatment and in one patient (# 20), improvement of cube copying was noted after treatment. Thus, there were also cases in whom improvement or worsening of higher cortical dysfunction was observed after remission or exacerbation of SLE activity. In these cases, higher cortical dysfunction is believed to have resulted from reversible changes, such as hypo function of cranial nerve cells, rather than from an irreversible process, such as cerebral infarction. Out of 16 patients with higher cortical dysfunction, 8 were found to have abnormalities on brain CT or SPECT. The relationship between these abnormalities and higher cortical dysfunction was not clear. This result would reflect that CT and SPECT detected morphological changes or organic abnormalities, whereas neuropsycho logical tests detected functional abnormalities. However, the finding of an abnormality on the neuropsychological tests may be thought to definitely indicate some disorder in the cerebral cortex. Therefore, even when no lesion is found on brain CT or SPECT, it cannot be concluded that no abnormality exists in the CNS. The etiology of CNS disorders in SLE may result from 1) cerebral vasculitis, 2) autoantibody reaction with nerve cells, or 3) thrombosis involving APA (13). However, cerebral vasculitis has actually been noted in only approximately ten percent of autopsied patients (13, 14) . It seems, therefore, that CNS cerebral vasculitis is uncommon. On the other hand, there have recently been several cases regarding APA (15-21) and much attention has been drawn to cerebrovascular obstruction due to this factor. In the binding of phospholipid in vascular endothelial cell membranes, APA is thought to inhibit the production or release of PG-I2, thereby inducing platelet aggregation to produce a thrombus (22) (23) (24) . Alternatively, APA may act by inducing platelet aggregation following reaction with phospholipid in platelet membranes (25, 26) , inhibition of prekallikrein (27), reducing anti-thrombin III (28) and inhibiting protein C (29). Among APA, the LA and IgG type of ACA seem to play an important role in causing throm bosis (30) (31) (32) (33) . Of the present subjects studied, only 4 had ACA. Furthermore, in 2 patients who had IgG ACA no higher cortical dysfunction was noted. On the other hand, all 6 patients who were positive for LA had higher cortical dysfunction. In LA positive patients, it was thought that cranial nerve cells were damaged by chronic brain circulation disturbances due to thrombi.
This suggests that the LA may be the cause of the higher cortical dysfunction. In conclusion, in SLE patients, a high incidence of higher cortical dysfunction such as lowered intelligence, mental function and constructional apraxia, is found. Further, LA may be an important factor in the pathogenesis of this higher cortical dysfunction.
